Parul Harish Kothari, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Exodeoxyribonucleases | 5 | 2018 | 180 | 0.990 |
Why?
|
| Phosphoproteins | 5 | 2018 | 2440 | 0.570 |
Why?
|
| Chromosomes, Human, Pair 17 | 1 | 2018 | 438 | 0.560 |
Why?
|
| Microglia | 1 | 2018 | 1266 | 0.360 |
Why?
|
| Frameshift Mutation | 3 | 2018 | 399 | 0.300 |
Why?
|
| Hereditary Central Nervous System Demyelinating Diseases | 2 | 2018 | 39 | 0.280 |
Why?
|
| Neoplasm Proteins | 2 | 2020 | 3703 | 0.280 |
Why?
|
| Asthma | 3 | 2022 | 6011 | 0.270 |
Why?
|
| Asthma, Aspirin-Induced | 2 | 2019 | 182 | 0.260 |
Why?
|
| Membrane Proteins | 2 | 2022 | 7879 | 0.250 |
Why?
|
| Retinal Diseases | 4 | 2018 | 683 | 0.250 |
Why?
|
| Brain Ischemia | 1 | 2018 | 3265 | 0.240 |
Why?
|
| Genetic Predisposition to Disease | 5 | 2022 | 17449 | 0.200 |
Why?
|
| Drug Hypersensitivity | 2 | 2020 | 883 | 0.200 |
Why?
|
| Receptors, Leukotriene | 1 | 2019 | 123 | 0.160 |
Why?
|
| Vascular Diseases | 2 | 2018 | 1161 | 0.160 |
Why?
|
| Receptors, Purinergic P2Y12 | 1 | 2018 | 132 | 0.150 |
Why?
|
| Retinal Vasculitis | 1 | 2016 | 42 | 0.140 |
Why?
|
| CADASIL | 1 | 2016 | 84 | 0.130 |
Why?
|
| Purinergic P2Y Receptor Antagonists | 1 | 2018 | 361 | 0.130 |
Why?
|
| CpG Islands | 1 | 2018 | 1172 | 0.110 |
Why?
|
| Brain | 2 | 2018 | 26413 | 0.110 |
Why?
|
| HeLa Cells | 1 | 2018 | 3129 | 0.100 |
Why?
|
| Pharmaceutical Preparations | 1 | 2020 | 1071 | 0.100 |
Why?
|
| Rabbits | 1 | 2018 | 4892 | 0.100 |
Why?
|
| Respiratory Tract Infections | 1 | 2019 | 961 | 0.100 |
Why?
|
| Antibodies | 1 | 2018 | 2461 | 0.090 |
Why?
|
| Quantitative Trait Loci | 1 | 2018 | 2019 | 0.090 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2019 | 2279 | 0.090 |
Why?
|
| HEK293 Cells | 1 | 2018 | 4201 | 0.080 |
Why?
|
| Autoimmunity | 1 | 2017 | 1349 | 0.080 |
Why?
|
| Homeostasis | 1 | 2018 | 3339 | 0.080 |
Why?
|
| Aspirin | 1 | 2019 | 3282 | 0.070 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2020 | 3047 | 0.060 |
Why?
|
| Macrophages | 1 | 2018 | 5657 | 0.060 |
Why?
|
| DNA Methylation | 1 | 2018 | 4289 | 0.060 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2008 | 587 | 0.060 |
Why?
|
| Genotype | 1 | 2018 | 12956 | 0.060 |
Why?
|
| Brain Diseases | 2 | 2008 | 1564 | 0.050 |
Why?
|
| Gene Expression Regulation | 1 | 2018 | 12075 | 0.040 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2018 | 15525 | 0.040 |
Why?
|
| Aclarubicin | 1 | 2017 | 12 | 0.040 |
Why?
|
| Epithelium | 1 | 2022 | 1680 | 0.040 |
Why?
|
| Desensitization, Immunologic | 1 | 2020 | 483 | 0.030 |
Why?
|
| Humans | 12 | 2022 | 744220 | 0.030 |
Why?
|
| Autophagy | 1 | 2022 | 1300 | 0.030 |
Why?
|
| Leukoencephalopathies | 1 | 2016 | 238 | 0.030 |
Why?
|
| Cross-Over Studies | 1 | 2018 | 2032 | 0.030 |
Why?
|
| Middle Aged | 4 | 2019 | 213367 | 0.030 |
Why?
|
| Amino Acid Substitution | 1 | 2017 | 1792 | 0.030 |
Why?
|
| Enzyme Activation | 1 | 2017 | 3701 | 0.020 |
Why?
|
| Cell Line | 2 | 2020 | 15999 | 0.020 |
Why?
|
| Aged | 2 | 2019 | 163253 | 0.020 |
Why?
|
| Animals | 2 | 2018 | 168788 | 0.020 |
Why?
|
| Calcium | 1 | 2022 | 5757 | 0.020 |
Why?
|
| Autoantibodies | 1 | 2017 | 2038 | 0.020 |
Why?
|
| Male | 4 | 2019 | 350027 | 0.020 |
Why?
|
| Female | 4 | 2019 | 380197 | 0.020 |
Why?
|
| Computational Biology | 1 | 2020 | 3523 | 0.020 |
Why?
|
| Genetic Association Studies | 1 | 2017 | 2702 | 0.020 |
Why?
|
| Sjogren's Syndrome | 1 | 2008 | 233 | 0.020 |
Why?
|
| Mutation | 2 | 2008 | 29784 | 0.020 |
Why?
|
| Retina | 1 | 2017 | 2616 | 0.020 |
Why?
|
| Genes, Dominant | 1 | 2007 | 880 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2017 | 9735 | 0.020 |
Why?
|
| Luminescent Proteins | 1 | 2007 | 853 | 0.020 |
Why?
|
| Double-Blind Method | 1 | 2018 | 12035 | 0.010 |
Why?
|
| Gene Expression | 1 | 2017 | 7799 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2020 | 9438 | 0.010 |
Why?
|
| B-Lymphocytes | 1 | 2017 | 4665 | 0.010 |
Why?
|
| Genome-Wide Association Study | 1 | 2022 | 12264 | 0.010 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2007 | 2839 | 0.010 |
Why?
|
| Cytoplasm | 1 | 2007 | 1539 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2020 | 19907 | 0.010 |
Why?
|
| Microscopy, Confocal | 1 | 2007 | 1971 | 0.010 |
Why?
|
| Apoptosis | 1 | 2017 | 9728 | 0.010 |
Why?
|
| Adult | 3 | 2019 | 214035 | 0.010 |
Why?
|
| Phenotype | 1 | 2017 | 16365 | 0.010 |
Why?
|
| Transfection | 1 | 2007 | 5892 | 0.010 |
Why?
|
| Kidney | 1 | 2014 | 7183 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2007 | 3772 | 0.010 |
Why?
|
| Cell Nucleus | 1 | 2007 | 2969 | 0.010 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2008 | 2103 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2007 | 13817 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2019 | 53280 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2019 | 57768 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2007 | 18116 | 0.010 |
Why?
|
| Mice | 1 | 2017 | 81178 | 0.010 |
Why?
|